Prova Education

How Similar are Biosimilar Insulins?

How Similar are Biosimilar Insulins?
RestartResume
Biosimilar insulin is an attractive market to a number of American and European pharmaceutical companies. Biosimilar insulin manufacture is complic...
  • Overview

    Biosimilar insulin is an attractive market to a number of American and European pharmaceutical companies. Biosimilar insulin manufacture is complicated for a number of reasons. Guest host Dr. Timothy Bailey talks with Dr. Lutz Heinemann, director of scientific services at Profil Institute for Clinical Research in San Diego and headquartered in Neuss, Germany, about the challenges and guidelines around producing safe and effective biosimilars. And, for healthcare providers, what are the practical aspects of switching to a biosimilar insulin?

Facebook Comments

Sign up for the Prova Education newsletters.

Better education for a better you.

* Required
Optional
Register

We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free